Skip to main content
Log in

Anti-inflammatory Effects of Sweroside on LPS-Induced ALI in Mice Via Activating SIRT1

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Sweroside, as one of the main components of Swertia L. in Gentianaceae, has the effect of clearing heat and detoxifying. In previous studies, sweroside has been reported to have anti-inflammatory effect on LPS-induced inflammation by alleviating NF-κB signaling pathway. In this paper, we investigate the anti-inflammatory effects of sweroside by establishing LPS-induced acute lung injury (ALI) model in mice. Experimental results showed that sweroside could reduce the wet-to-dry ratio of the lung and inhibit MPO activity. In addition, it turned out that sweroside reduced pathological changes in lung tissue and the numbers of inflammatory cells. Moreover, sweroside significantly reduced the levels of inflammatory cytokines and down-regulated the NF-κB signaling pathway. And the results demonstrated that sweroside could increase the expression of SIRT1, and the protective effects of sweroside on LPS-induced ALI were reversed by SIRT1 inhibitor EX-527. In conclusion, sweroside can protect LPS-induced ALI mice through inhibiting inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The data used to support the findings of this study are available from the corresponding author upon request.

References

  1. Ferguson, N.D., F. Frutos-Vivar, A. Esteban, P. Fernandez-Segoviano, J.A. Aramburu, L. Najera, and T.E. Stewart. 2005. Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 33: 2228–2234.

    Article  Google Scholar 

  2. Goodman, R.B., J. Pugin, J.S. Lee, and M.A. Matthay. 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine & Growth Factor Reviews 14: 523–535.

    Article  CAS  Google Scholar 

  3. Murray, J.F., M.A. Matthay, J.M. Luce, and M.R. Flick. 1988. An expanded definition of the adult respiratory-distress syndrome. American Review of Respiratory Disease 138: 720–723.

    Article  CAS  Google Scholar 

  4. Ruffini, E., A. Parola, E. Papalia, P.L. Filosso, M. Mancuso, A. Oliaro, G. Actis-Dato, and G. Maggi. 2001. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma. European Journal of Cardio-Thoracic Surgery 20: 30–37.

    Article  CAS  Google Scholar 

  5. Blank, R., and L.M. Napolitano. 2011. Epidemiology of ARDS and ALI. Crit Care Clin 27: 439–458.

    Article  Google Scholar 

  6. Fitzgerald, K.A., D.C. Rowe, and D.T. Golenbock. 2004. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect 6: 1361–1367.

    Article  CAS  Google Scholar 

  7. Lu, Y.C., W.C. Yeh, and P.S. Ohashi. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145–151.

    Article  CAS  Google Scholar 

  8. Wang, R., Z.Y. Dong, X.Z. Lan, Z.H. Liao, and M. Chen. 2019. Sweroside Alleviated LPS-induced inflammation via SIRT1 mediating NF-kappa B and FOXO1 signaling pathways in RAW264.7 Cells. Molecules 24.

  9. Zhang, R., C.M. Wang, H.J. Jiang, X.G. Tian, W.J. Li, W. Liang, J.H. Yang, C.L. Zhong, Y.H. Chen, and T. Li. 2019. Protective effects of sweroside on IL-1-induced inflammation in rat articular chondrocytes through suppression of NF-B and mTORC1 signaling pathway. Inflammation 42: 496–505.

    Article  CAS  Google Scholar 

  10. Yang, Q.L., F. Yang, J.T. Gong, X.W. Tang, G.Y. Wang, Z.T. Wang, and L. Yang. 2016. Sweroside ameliorates alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses. Acta Pharmacologica Sinica 37: 1218–1228.

    Article  CAS  Google Scholar 

  11. Spragg, R.G., G.R. Bernard, W. Checkley, J.R. Curtis, O. Gajic, G. Guyatt, J. Hall, E. Israel, M. Jain, D.M. Needham, A.G. Randolph, G.D. Rubenfeld, D. Schoenfeld, B.T. Thompson, L.B. Ware, D. Young, and A.L. Harabin. 2010. Beyond mortality future clinical research in acute lung injury. American Journal of Respiratory and Critical Care Medicine 181: 1121–1127.

    Article  Google Scholar 

  12. Parker, J.C. 2011. Acute lung injury and pulmonary vascular permeability: use of transgenic models. Comprehensive Physiology 1: 835–882.

    Article  Google Scholar 

  13. De Luca, D., M. Piastra, F. Tosi, S. Pulitano, A. Mancino, O. Genovese, D. Pietrini, and G. Conti. 2012. Pharmacological Therapies for pediatric and neonatal ALI/ARDS: an evidence-based review. Current Drug Targets 13: 906–916.

    Article  Google Scholar 

  14. Zhong, W.T., Y.W. Cui, Q.L. Yu, X.X. Xie, Y. Liu, M.M. Wei, X.X. Ci, and L.P. Peng. 2014. Modulation of LPS-Stimulated pulmonary inflammation by borneol in murine acute lung injury model. Inflammation 37: 1148–1157.

    Article  CAS  Google Scholar 

  15. Chen, H., C. Bai, and X. Wang. 2010. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev Respir Med 4: 773–783.

    Article  CAS  Google Scholar 

  16. Chignard, M., and V. Balloy. 2000. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. American Journal of Physiology-Lung Cellular and Molecular Physiology 279: L1083–L1090.

    Article  CAS  Google Scholar 

  17. Kawai, T., and S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13: 460–469.

    Article  CAS  Google Scholar 

  18. Maruyama, K., Y. Takada, N. Ray, Y. Kishimoto, J.M. Penninger, H. Yasuda, and K. Matsuo. 2006. Receptor activator of NF-kappa B ligand and osteoprotegerin regulate proinflammatory cytokine production in mice. Journal of Immunology 177: 3799–3805.

    Article  CAS  Google Scholar 

  19. Rahman, A., and F. Fazal. 2011. Blocking NF-kappaB: an inflammatory issue. Proc Am Thorac Soc 8: 497–503.

    Article  CAS  Google Scholar 

  20. Xie, J., X.M. Zhang, and L. Zhang. 2013. Negative regulation of inflammation by SIRT1. Pharmacological Research 67: 60–67.

    Article  CAS  Google Scholar 

  21. Hwang, J.W., H.W. Yao, S. Caito, I.K. Sundar, and I. Rahman. 2013. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radical Biology and Medicine 61: 95–110.

    Article  CAS  Google Scholar 

  22. Yang, H.Y., W. Zhang, H. Pan, H.G. Feldser, E. Lainez, C. Miller, S. Leung, Z. Zhong, H.Z. Zhao, S. Sweitzer, et al. 2012. SIRT1 activators suppress inflammatory responses through promotion of p65 Deacetylation and inhibition of NF-kappa B activity. Plos One 7.

  23. Tian, Y.L., J.T. Ma, W.D. Wang, L.J. Zhang, J. Xu, K. Wang, and D.F. Li. 2016. Resveratrol supplement inhibited the NF-kappa B inflammation pathway through activating AMPK alpha-SIRT1 pathway in mice with fatty liver. Molecular and Cellular Biochemistry 422: 75–84.

    Article  CAS  Google Scholar 

  24. Yuan, Q., D.Q. Zhang, C.Q. Liu, C.C. Zhang, and D. Yuan. 2018. Chikusetsusaponin V inhibits LPS-activated inflammatory responses via SIRT1/NF-B signaling pathway in RAW264.7 cells. Inflammation 41: 2149–2159.

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by the grant for Key Research and Development Project of Shandong Province (2019GSF108265).

Author information

Authors and Affiliations

Authors

Contributions

Juan Wang and Fengshan Wang designed the experiment; Juan Wang, Xiaolan Cai, Rui Ma, and Dapeng Lei did the experiment; Xinliang Pan analyzed the data; Juan Wang and Xiaolan Cai revised the paper; Juan Wang wrote the paper.

Corresponding authors

Correspondence to Juan Wang or Fengshan Wang.

Ethics declarations

Ethics Approval and Consent to Participate

All the experimental protocols in this study were approved by the Institutional Animal Care and Use Committee of Shandong University. All authors consent to participate this research.

Consent for Publication

All authors consent to publish this article.

Competing Interests

All authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, J., Cai, X., Ma, R. et al. Anti-inflammatory Effects of Sweroside on LPS-Induced ALI in Mice Via Activating SIRT1. Inflammation 44, 1961–1968 (2021). https://doi.org/10.1007/s10753-021-01473-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-021-01473-4

KEY WORDS

Navigation